Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic gastrointestinal bacteria are diverse microorganisms that can colonize and infect the human digestive tract, causing a range of clinical manifestations from mild self-limiting diarrhea to severe, life-threatening conditions. These bacteria employ various virulence mechanisms including toxin production, invasion of intestinal epithelium, and adhesion to mucosal surfaces to cause disease. They can be classified based on their Gram staining properties (positive or negative), oxygen requirements (aerobic, anaerobic, or facultative), and morphology (cocci, bacilli, or spiral-shaped). Common pathogenic gastrointestinal bacteria include Salmonella, Shigella, Campylobacter, pathogenic E. coli strains, Listeria, and Clostridium difficile. Diagnosis typically involves stool culture, molecular testing, or antigen detection, while treatment may include antibiotics, supportive care, and rehydration. Prevention strategies focus on food safety, proper hygiene, and vaccination where available. These bacteria represent important therapeutic targets due to their significant global disease burden, particularly in developing countries and among vulnerable populations.
Antibiotics: Inhibition of bacterial cell wall synthesis, protein synthesis, or DNA replication; Probiotics: Competitive inhibition of pathogen colonization; Antimotility agents: Reduction of intestinal motility; Antidiarrheal medications: Absorption of water and reduction of fluid loss.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic gastrointestinal bacteria.